X-ZELL technology featured in British urology journal

Ground-breaking X-ZELL research featured in BJU International Oxford, August 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has published new research into the utility of tumour-associated Circulating Endothelial Cells (tCEC) for the detection of early-stage prostate cancer....